This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received... from 45 Member States.
more
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
In addition to the ongoing humanitarian emergencies in the country, the COVID-19 pandemic poses a potential monumental social and economic threat to Nigeria, with a devastating knock on effect for the most vulnerable population in the BAY states who have endured a decade of conflict. The UN system i...n Nigeria launched a One UN Response Plan to COVID-19 to support the rapid implementation of the Government’s National COVID-19 Multi-Sectoral Pandemic Response Plan and will continue to support strong coordination and coherence with all stakeholders responding to the pandemic.
more
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID...-19 on routine immunization, leaving millions of children unprotected from preventable diseases. It calls for urgent measures to restore and improve vaccination coverage, ensure equity in vaccine access, strengthen primary healthcare systems, and build trust in vaccines. The report also advocates for innovations and sustainable funding to achieve immunization for every child.
more
Combler les écarts
Rompre les barrières
Réparer les injustices
Synthèse
Trouble de l'humeur
Chapitre E.2
Edition en français Traduction : Xavier Benarous Sous la direction de : David Cohen Avec le soutien de la SFPEADA
Le présent rapport fait un apperçu sur la situation de la riposte au VIH/Sida en 2015 au Burkina Faso. Il se veut être, un outil de sensibilisation, de plaidoyer, d’information, et d’orientations sur les décisions programmatiques, et également sur les efforts de mobilisation des ressources,... et de suivi évaluation.
more
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...ises, emphasizing their effectiveness in reducing cases and mortality. The paper discusses two types of OCVs (Dukoral®, Shanchol™, Euvichol®) and supports the WHO-managed vaccine stockpile for rapid deployment in cholera-prone regions.
more
Weekly epidemiological record.
Chad was validated for the elimination of gambiense HAT as a public health problem in April 2024, and the work continues towards interrupting transmission further.
English and French.
WEEKLY EPIDEMIOLOGICAL RECORD, NO 37, 13 SEPTEMBER 2024, 505-524
Trouble de l'humeur
Chapitre E.3
Edition en français Traduction : Xavier Benarous
Sous la direction de : David Cohen
Avec le soutien de la SFPEADA
Convention de sauvegarde des droits de l’homme et des libertés fondamentales - Version de 2010 .
Pour les versions en anglais, allemand, italien et russe allez voir sur la page:
http://www.cö.int/en/web/conventions/full-list/-/conventions/treaty/005?_cöconventions_WAR_cöconventionsportlet_la...nguageId=fr_FR
more
Troubles de l'humeur
Chapitre E.1
Edition en français
Traduction : Marie Boussaud, Julie Brunelle Sous la direction de : David Cohen Avec le soutien de la SFPEADA
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by... national public health officials and managers of immunization programmes.
This paper focuses on the second licensed dengue vaccine, TAK-003 (Qdenga, Takeda), along with WHO’s position for its use, and provides an update on the first licensed dengue vaccine, CYD-TDV.
more